NCT00181818View on ClinicalTrials.gov

Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

248

Participants

Timeline

Start Date

October 31, 1999

Study Completion Date

December 31, 2003

Conditions

SmokingMyocardial InfarctionUnstable AnginaCardiovascular Disease

Interventions

DRUG

bupropion SR (sustained-release)

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

GlaxoSmithKline

INDUSTRY

lead

Massachusetts General Hospital

OTHER